nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadodiamide—Hyponatraemia—Cisplatin—bone cancer	0.0062	0.0062	CcSEcCtD
Gadodiamide—Lung disorder—Epirubicin—bone cancer	0.00617	0.00617	CcSEcCtD
Gadodiamide—Blood creatinine increased—Cisplatin—bone cancer	0.00578	0.00578	CcSEcCtD
Gadodiamide—Lung disorder—Doxorubicin—bone cancer	0.00571	0.00571	CcSEcCtD
Gadodiamide—Rash erythematous—Epirubicin—bone cancer	0.0057	0.0057	CcSEcCtD
Gadodiamide—Feeling hot—Epirubicin—bone cancer	0.00557	0.00557	CcSEcCtD
Gadodiamide—Ageusia—Epirubicin—bone cancer	0.00539	0.00539	CcSEcCtD
Gadodiamide—Injection site pain—Epirubicin—bone cancer	0.00535	0.00535	CcSEcCtD
Gadodiamide—Rigors—Epirubicin—bone cancer	0.00535	0.00535	CcSEcCtD
Gadodiamide—Extravasation—Methotrexate—bone cancer	0.00535	0.00535	CcSEcCtD
Gadodiamide—Rash erythematous—Doxorubicin—bone cancer	0.00528	0.00528	CcSEcCtD
Gadodiamide—Sweating increased—Cisplatin—bone cancer	0.0052	0.0052	CcSEcCtD
Gadodiamide—Feeling hot—Doxorubicin—bone cancer	0.00515	0.00515	CcSEcCtD
Gadodiamide—Extravasation—Epirubicin—bone cancer	0.00501	0.00501	CcSEcCtD
Gadodiamide—Ageusia—Doxorubicin—bone cancer	0.00499	0.00499	CcSEcCtD
Gadodiamide—Vasodilation—Epirubicin—bone cancer	0.00497	0.00497	CcSEcCtD
Gadodiamide—Vasodilation procedure—Epirubicin—bone cancer	0.00497	0.00497	CcSEcCtD
Gadodiamide—Cardiovascular disorder—Epirubicin—bone cancer	0.00497	0.00497	CcSEcCtD
Gadodiamide—Injection site pain—Doxorubicin—bone cancer	0.00495	0.00495	CcSEcCtD
Gadodiamide—Rigors—Doxorubicin—bone cancer	0.00495	0.00495	CcSEcCtD
Gadodiamide—Hepatic enzyme increased—Methotrexate—bone cancer	0.00494	0.00494	CcSEcCtD
Gadodiamide—Acute coronary syndrome—Cisplatin—bone cancer	0.00469	0.00469	CcSEcCtD
Gadodiamide—Renal failure—Cisplatin—bone cancer	0.00468	0.00468	CcSEcCtD
Gadodiamide—Myocardial infarction—Cisplatin—bone cancer	0.00466	0.00466	CcSEcCtD
Gadodiamide—Neuropathy peripheral—Cisplatin—bone cancer	0.00466	0.00466	CcSEcCtD
Gadodiamide—Extravasation—Doxorubicin—bone cancer	0.00463	0.00463	CcSEcCtD
Gadodiamide—Vasodilation—Doxorubicin—bone cancer	0.0046	0.0046	CcSEcCtD
Gadodiamide—Vasodilation procedure—Doxorubicin—bone cancer	0.0046	0.0046	CcSEcCtD
Gadodiamide—Cardiovascular disorder—Doxorubicin—bone cancer	0.0046	0.0046	CcSEcCtD
Gadodiamide—Melaena—Methotrexate—bone cancer	0.00456	0.00456	CcSEcCtD
Gadodiamide—Coordination abnormal—Epirubicin—bone cancer	0.00445	0.00445	CcSEcCtD
Gadodiamide—Injection site reaction—Epirubicin—bone cancer	0.00434	0.00434	CcSEcCtD
Gadodiamide—Eructation—Epirubicin—bone cancer	0.00429	0.00429	CcSEcCtD
Gadodiamide—Melaena—Epirubicin—bone cancer	0.00427	0.00427	CcSEcCtD
Gadodiamide—Coma—Methotrexate—bone cancer	0.00427	0.00427	CcSEcCtD
Gadodiamide—Urinary tract disorder—Cisplatin—bone cancer	0.00422	0.00422	CcSEcCtD
Gadodiamide—Urethral disorder—Cisplatin—bone cancer	0.00419	0.00419	CcSEcCtD
Gadodiamide—Visual impairment—Cisplatin—bone cancer	0.00412	0.00412	CcSEcCtD
Gadodiamide—Coordination abnormal—Doxorubicin—bone cancer	0.00412	0.00412	CcSEcCtD
Gadodiamide—Injection site reaction—Doxorubicin—bone cancer	0.00402	0.00402	CcSEcCtD
Gadodiamide—Coma—Epirubicin—bone cancer	0.00399	0.00399	CcSEcCtD
Gadodiamide—Tinnitus—Cisplatin—bone cancer	0.00398	0.00398	CcSEcCtD
Gadodiamide—Eructation—Doxorubicin—bone cancer	0.00397	0.00397	CcSEcCtD
Gadodiamide—Flushing—Cisplatin—bone cancer	0.00396	0.00396	CcSEcCtD
Gadodiamide—Melaena—Doxorubicin—bone cancer	0.00395	0.00395	CcSEcCtD
Gadodiamide—Arrhythmia—Cisplatin—bone cancer	0.00382	0.00382	CcSEcCtD
Gadodiamide—Abnormal vision—Epirubicin—bone cancer	0.00381	0.00381	CcSEcCtD
Gadodiamide—Coma—Doxorubicin—bone cancer	0.00369	0.00369	CcSEcCtD
Gadodiamide—Phlebitis—Epirubicin—bone cancer	0.00368	0.00368	CcSEcCtD
Gadodiamide—Renal failure acute—Methotrexate—bone cancer	0.00367	0.00367	CcSEcCtD
Gadodiamide—Visual disturbance—Methotrexate—bone cancer	0.00358	0.00358	CcSEcCtD
Gadodiamide—Abnormal vision—Doxorubicin—bone cancer	0.00353	0.00353	CcSEcCtD
Gadodiamide—Anaphylactoid reaction—Methotrexate—bone cancer	0.0035	0.0035	CcSEcCtD
Gadodiamide—Tremor—Cisplatin—bone cancer	0.00348	0.00348	CcSEcCtD
Gadodiamide—Ill-defined disorder—Cisplatin—bone cancer	0.00345	0.00345	CcSEcCtD
Gadodiamide—Renal failure acute—Epirubicin—bone cancer	0.00343	0.00343	CcSEcCtD
Gadodiamide—Phlebitis—Doxorubicin—bone cancer	0.00341	0.00341	CcSEcCtD
Gadodiamide—Hot flush—Epirubicin—bone cancer	0.00339	0.00339	CcSEcCtD
Gadodiamide—Menopausal symptoms—Epirubicin—bone cancer	0.00336	0.00336	CcSEcCtD
Gadodiamide—Malaise—Cisplatin—bone cancer	0.00335	0.00335	CcSEcCtD
Gadodiamide—Renal impairment—Epirubicin—bone cancer	0.00333	0.00333	CcSEcCtD
Gadodiamide—Anaphylactoid reaction—Epirubicin—bone cancer	0.00328	0.00328	CcSEcCtD
Gadodiamide—Cardiac failure—Epirubicin—bone cancer	0.00325	0.00325	CcSEcCtD
Gadodiamide—Convulsion—Cisplatin—bone cancer	0.00322	0.00322	CcSEcCtD
Gadodiamide—Ataxia—Methotrexate—bone cancer	0.00319	0.00319	CcSEcCtD
Gadodiamide—Hyponatraemia—Epirubicin—bone cancer	0.00318	0.00318	CcSEcCtD
Gadodiamide—Renal failure acute—Doxorubicin—bone cancer	0.00318	0.00318	CcSEcCtD
Gadodiamide—Myalgia—Cisplatin—bone cancer	0.00317	0.00317	CcSEcCtD
Gadodiamide—Anxiety—Cisplatin—bone cancer	0.00315	0.00315	CcSEcCtD
Gadodiamide—Hot flush—Doxorubicin—bone cancer	0.00314	0.00314	CcSEcCtD
Gadodiamide—Discomfort—Cisplatin—bone cancer	0.00313	0.00313	CcSEcCtD
Gadodiamide—Migraine—Epirubicin—bone cancer	0.00312	0.00312	CcSEcCtD
Gadodiamide—Menopausal symptoms—Doxorubicin—bone cancer	0.00311	0.00311	CcSEcCtD
Gadodiamide—Renal impairment—Doxorubicin—bone cancer	0.00308	0.00308	CcSEcCtD
Gadodiamide—Oedema—Cisplatin—bone cancer	0.00303	0.00303	CcSEcCtD
Gadodiamide—Anaphylactic shock—Cisplatin—bone cancer	0.00303	0.00303	CcSEcCtD
Gadodiamide—Anaphylactoid reaction—Doxorubicin—bone cancer	0.00303	0.00303	CcSEcCtD
Gadodiamide—Infection—Cisplatin—bone cancer	0.00302	0.00302	CcSEcCtD
Gadodiamide—Cardiac failure—Doxorubicin—bone cancer	0.00301	0.00301	CcSEcCtD
Gadodiamide—Ataxia—Epirubicin—bone cancer	0.00298	0.00298	CcSEcCtD
Gadodiamide—Nervous system disorder—Cisplatin—bone cancer	0.00298	0.00298	CcSEcCtD
Gadodiamide—Blood creatinine increased—Epirubicin—bone cancer	0.00297	0.00297	CcSEcCtD
Gadodiamide—Tachycardia—Cisplatin—bone cancer	0.00296	0.00296	CcSEcCtD
Gadodiamide—Hyponatraemia—Doxorubicin—bone cancer	0.00295	0.00295	CcSEcCtD
Gadodiamide—Hyperhidrosis—Cisplatin—bone cancer	0.00293	0.00293	CcSEcCtD
Gadodiamide—Migraine—Doxorubicin—bone cancer	0.00289	0.00289	CcSEcCtD
Gadodiamide—Hypotension—Cisplatin—bone cancer	0.00284	0.00284	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Cisplatin—bone cancer	0.00276	0.00276	CcSEcCtD
Gadodiamide—Ataxia—Doxorubicin—bone cancer	0.00276	0.00276	CcSEcCtD
Gadodiamide—Blood creatinine increased—Doxorubicin—bone cancer	0.00275	0.00275	CcSEcCtD
Gadodiamide—Paraesthesia—Cisplatin—bone cancer	0.00273	0.00273	CcSEcCtD
Gadodiamide—Dyspnoea—Cisplatin—bone cancer	0.00271	0.00271	CcSEcCtD
Gadodiamide—Pain—Cisplatin—bone cancer	0.0026	0.0026	CcSEcCtD
Gadodiamide—Renal failure—Methotrexate—bone cancer	0.00257	0.00257	CcSEcCtD
Gadodiamide—Feeling abnormal—Cisplatin—bone cancer	0.0025	0.0025	CcSEcCtD
Gadodiamide—Renal failure—Epirubicin—bone cancer	0.0024	0.0024	CcSEcCtD
Gadodiamide—Body temperature increased—Cisplatin—bone cancer	0.0024	0.0024	CcSEcCtD
Gadodiamide—Neuropathy peripheral—Epirubicin—bone cancer	0.0024	0.0024	CcSEcCtD
Gadodiamide—Pharyngitis—Methotrexate—bone cancer	0.00233	0.00233	CcSEcCtD
Gadodiamide—Urinary tract disorder—Methotrexate—bone cancer	0.00231	0.00231	CcSEcCtD
Gadodiamide—Urethral disorder—Methotrexate—bone cancer	0.0023	0.0023	CcSEcCtD
Gadodiamide—Visual impairment—Methotrexate—bone cancer	0.00226	0.00226	CcSEcCtD
Gadodiamide—Hypersensitivity—Cisplatin—bone cancer	0.00224	0.00224	CcSEcCtD
Gadodiamide—Renal failure—Doxorubicin—bone cancer	0.00222	0.00222	CcSEcCtD
Gadodiamide—Neuropathy peripheral—Doxorubicin—bone cancer	0.00222	0.00222	CcSEcCtD
Gadodiamide—Rhinitis—Epirubicin—bone cancer	0.0022	0.0022	CcSEcCtD
Gadodiamide—Tinnitus—Methotrexate—bone cancer	0.00219	0.00219	CcSEcCtD
Gadodiamide—Asthenia—Cisplatin—bone cancer	0.00218	0.00218	CcSEcCtD
Gadodiamide—Pharyngitis—Epirubicin—bone cancer	0.00218	0.00218	CcSEcCtD
Gadodiamide—Urinary tract disorder—Epirubicin—bone cancer	0.00217	0.00217	CcSEcCtD
Gadodiamide—Urethral disorder—Epirubicin—bone cancer	0.00215	0.00215	CcSEcCtD
Gadodiamide—Visual impairment—Epirubicin—bone cancer	0.00211	0.00211	CcSEcCtD
Gadodiamide—Chills—Methotrexate—bone cancer	0.0021	0.0021	CcSEcCtD
Gadodiamide—Diarrhoea—Cisplatin—bone cancer	0.00208	0.00208	CcSEcCtD
Gadodiamide—Tinnitus—Epirubicin—bone cancer	0.00205	0.00205	CcSEcCtD
Gadodiamide—Flushing—Epirubicin—bone cancer	0.00204	0.00204	CcSEcCtD
Gadodiamide—Rhinitis—Doxorubicin—bone cancer	0.00203	0.00203	CcSEcCtD
Gadodiamide—Pharyngitis—Doxorubicin—bone cancer	0.00201	0.00201	CcSEcCtD
Gadodiamide—Urinary tract disorder—Doxorubicin—bone cancer	0.002	0.002	CcSEcCtD
Gadodiamide—Dysgeusia—Methotrexate—bone cancer	0.002	0.002	CcSEcCtD
Gadodiamide—Urethral disorder—Doxorubicin—bone cancer	0.00199	0.00199	CcSEcCtD
Gadodiamide—Chills—Epirubicin—bone cancer	0.00197	0.00197	CcSEcCtD
Gadodiamide—Arrhythmia—Epirubicin—bone cancer	0.00196	0.00196	CcSEcCtD
Gadodiamide—Visual impairment—Doxorubicin—bone cancer	0.00196	0.00196	CcSEcCtD
Gadodiamide—Vomiting—Cisplatin—bone cancer	0.00193	0.00193	CcSEcCtD
Gadodiamide—Rash—Cisplatin—bone cancer	0.00191	0.00191	CcSEcCtD
Gadodiamide—Dermatitis—Cisplatin—bone cancer	0.00191	0.00191	CcSEcCtD
Gadodiamide—Ill-defined disorder—Methotrexate—bone cancer	0.00189	0.00189	CcSEcCtD
Gadodiamide—Tinnitus—Doxorubicin—bone cancer	0.00189	0.00189	CcSEcCtD
Gadodiamide—Flushing—Doxorubicin—bone cancer	0.00188	0.00188	CcSEcCtD
Gadodiamide—Dysgeusia—Epirubicin—bone cancer	0.00187	0.00187	CcSEcCtD
Gadodiamide—Malaise—Methotrexate—bone cancer	0.00184	0.00184	CcSEcCtD
Gadodiamide—Chills—Doxorubicin—bone cancer	0.00182	0.00182	CcSEcCtD
Gadodiamide—Arrhythmia—Doxorubicin—bone cancer	0.00181	0.00181	CcSEcCtD
Gadodiamide—Nausea—Cisplatin—bone cancer	0.0018	0.0018	CcSEcCtD
Gadodiamide—Ill-defined disorder—Epirubicin—bone cancer	0.00177	0.00177	CcSEcCtD
Gadodiamide—Convulsion—Methotrexate—bone cancer	0.00177	0.00177	CcSEcCtD
Gadodiamide—Chest pain—Methotrexate—bone cancer	0.00174	0.00174	CcSEcCtD
Gadodiamide—Myalgia—Methotrexate—bone cancer	0.00174	0.00174	CcSEcCtD
Gadodiamide—Arthralgia—Methotrexate—bone cancer	0.00174	0.00174	CcSEcCtD
Gadodiamide—Dysgeusia—Doxorubicin—bone cancer	0.00173	0.00173	CcSEcCtD
Gadodiamide—Malaise—Epirubicin—bone cancer	0.00172	0.00172	CcSEcCtD
Gadodiamide—Discomfort—Methotrexate—bone cancer	0.00172	0.00172	CcSEcCtD
Gadodiamide—Syncope—Epirubicin—bone cancer	0.00171	0.00171	CcSEcCtD
Gadodiamide—Loss of consciousness—Epirubicin—bone cancer	0.00168	0.00168	CcSEcCtD
Gadodiamide—Anaphylactic shock—Methotrexate—bone cancer	0.00167	0.00167	CcSEcCtD
Gadodiamide—Convulsion—Epirubicin—bone cancer	0.00165	0.00165	CcSEcCtD
Gadodiamide—Infection—Methotrexate—bone cancer	0.00165	0.00165	CcSEcCtD
Gadodiamide—Ill-defined disorder—Doxorubicin—bone cancer	0.00164	0.00164	CcSEcCtD
Gadodiamide—Nervous system disorder—Methotrexate—bone cancer	0.00163	0.00163	CcSEcCtD
Gadodiamide—Myalgia—Epirubicin—bone cancer	0.00163	0.00163	CcSEcCtD
Gadodiamide—Chest pain—Epirubicin—bone cancer	0.00163	0.00163	CcSEcCtD
Gadodiamide—Arthralgia—Epirubicin—bone cancer	0.00163	0.00163	CcSEcCtD
Gadodiamide—Anxiety—Epirubicin—bone cancer	0.00162	0.00162	CcSEcCtD
Gadodiamide—Hyperhidrosis—Methotrexate—bone cancer	0.00161	0.00161	CcSEcCtD
Gadodiamide—Discomfort—Epirubicin—bone cancer	0.00161	0.00161	CcSEcCtD
Gadodiamide—Malaise—Doxorubicin—bone cancer	0.00159	0.00159	CcSEcCtD
Gadodiamide—Dry mouth—Epirubicin—bone cancer	0.00159	0.00159	CcSEcCtD
Gadodiamide—Syncope—Doxorubicin—bone cancer	0.00158	0.00158	CcSEcCtD
Gadodiamide—Anaphylactic shock—Epirubicin—bone cancer	0.00156	0.00156	CcSEcCtD
Gadodiamide—Oedema—Epirubicin—bone cancer	0.00156	0.00156	CcSEcCtD
Gadodiamide—Hypotension—Methotrexate—bone cancer	0.00156	0.00156	CcSEcCtD
Gadodiamide—Loss of consciousness—Doxorubicin—bone cancer	0.00155	0.00155	CcSEcCtD
Gadodiamide—Infection—Epirubicin—bone cancer	0.00155	0.00155	CcSEcCtD
Gadodiamide—Shock—Epirubicin—bone cancer	0.00153	0.00153	CcSEcCtD
Gadodiamide—Convulsion—Doxorubicin—bone cancer	0.00153	0.00153	CcSEcCtD
Gadodiamide—Nervous system disorder—Epirubicin—bone cancer	0.00153	0.00153	CcSEcCtD
Gadodiamide—Tachycardia—Epirubicin—bone cancer	0.00152	0.00152	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Methotrexate—bone cancer	0.00152	0.00152	CcSEcCtD
Gadodiamide—Hyperhidrosis—Epirubicin—bone cancer	0.00151	0.00151	CcSEcCtD
Gadodiamide—Arthralgia—Doxorubicin—bone cancer	0.0015	0.0015	CcSEcCtD
Gadodiamide—Myalgia—Doxorubicin—bone cancer	0.0015	0.0015	CcSEcCtD
Gadodiamide—Chest pain—Doxorubicin—bone cancer	0.0015	0.0015	CcSEcCtD
Gadodiamide—Anxiety—Doxorubicin—bone cancer	0.0015	0.0015	CcSEcCtD
Gadodiamide—Paraesthesia—Methotrexate—bone cancer	0.0015	0.0015	CcSEcCtD
Gadodiamide—Discomfort—Doxorubicin—bone cancer	0.00149	0.00149	CcSEcCtD
Gadodiamide—Dyspnoea—Methotrexate—bone cancer	0.00148	0.00148	CcSEcCtD
Gadodiamide—Somnolence—Methotrexate—bone cancer	0.00148	0.00148	CcSEcCtD
Gadodiamide—Dry mouth—Doxorubicin—bone cancer	0.00147	0.00147	CcSEcCtD
Gadodiamide—Dyspepsia—Methotrexate—bone cancer	0.00147	0.00147	CcSEcCtD
Gadodiamide—Hypotension—Epirubicin—bone cancer	0.00146	0.00146	CcSEcCtD
Gadodiamide—Anaphylactic shock—Doxorubicin—bone cancer	0.00144	0.00144	CcSEcCtD
Gadodiamide—Oedema—Doxorubicin—bone cancer	0.00144	0.00144	CcSEcCtD
Gadodiamide—Fatigue—Methotrexate—bone cancer	0.00144	0.00144	CcSEcCtD
Gadodiamide—Infection—Doxorubicin—bone cancer	0.00143	0.00143	CcSEcCtD
Gadodiamide—Pain—Methotrexate—bone cancer	0.00142	0.00142	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Epirubicin—bone cancer	0.00142	0.00142	CcSEcCtD
Gadodiamide—Shock—Doxorubicin—bone cancer	0.00142	0.00142	CcSEcCtD
Gadodiamide—Nervous system disorder—Doxorubicin—bone cancer	0.00141	0.00141	CcSEcCtD
Gadodiamide—Tachycardia—Doxorubicin—bone cancer	0.00141	0.00141	CcSEcCtD
Gadodiamide—Paraesthesia—Epirubicin—bone cancer	0.0014	0.0014	CcSEcCtD
Gadodiamide—Hyperhidrosis—Doxorubicin—bone cancer	0.00139	0.00139	CcSEcCtD
Gadodiamide—Dyspnoea—Epirubicin—bone cancer	0.00139	0.00139	CcSEcCtD
Gadodiamide—Somnolence—Epirubicin—bone cancer	0.00139	0.00139	CcSEcCtD
Gadodiamide—Feeling abnormal—Methotrexate—bone cancer	0.00137	0.00137	CcSEcCtD
Gadodiamide—Dyspepsia—Epirubicin—bone cancer	0.00137	0.00137	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Methotrexate—bone cancer	0.00136	0.00136	CcSEcCtD
Gadodiamide—Hypotension—Doxorubicin—bone cancer	0.00135	0.00135	CcSEcCtD
Gadodiamide—Fatigue—Epirubicin—bone cancer	0.00134	0.00134	CcSEcCtD
Gadodiamide—Pain—Epirubicin—bone cancer	0.00133	0.00133	CcSEcCtD
Gadodiamide—Urticaria—Methotrexate—bone cancer	0.00132	0.00132	CcSEcCtD
Gadodiamide—Abdominal pain—Methotrexate—bone cancer	0.00132	0.00132	CcSEcCtD
Gadodiamide—Body temperature increased—Methotrexate—bone cancer	0.00132	0.00132	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.00131	0.00131	CcSEcCtD
Gadodiamide—Paraesthesia—Doxorubicin—bone cancer	0.00129	0.00129	CcSEcCtD
Gadodiamide—Dyspnoea—Doxorubicin—bone cancer	0.00129	0.00129	CcSEcCtD
Gadodiamide—Feeling abnormal—Epirubicin—bone cancer	0.00128	0.00128	CcSEcCtD
Gadodiamide—Somnolence—Doxorubicin—bone cancer	0.00128	0.00128	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Epirubicin—bone cancer	0.00127	0.00127	CcSEcCtD
Gadodiamide—Dyspepsia—Doxorubicin—bone cancer	0.00127	0.00127	CcSEcCtD
Gadodiamide—Fatigue—Doxorubicin—bone cancer	0.00124	0.00124	CcSEcCtD
Gadodiamide—Urticaria—Epirubicin—bone cancer	0.00124	0.00124	CcSEcCtD
Gadodiamide—Pain—Doxorubicin—bone cancer	0.00123	0.00123	CcSEcCtD
Gadodiamide—Abdominal pain—Epirubicin—bone cancer	0.00123	0.00123	CcSEcCtD
Gadodiamide—Body temperature increased—Epirubicin—bone cancer	0.00123	0.00123	CcSEcCtD
Gadodiamide—Hypersensitivity—Methotrexate—bone cancer	0.00123	0.00123	CcSEcCtD
Gadodiamide—Asthenia—Methotrexate—bone cancer	0.00119	0.00119	CcSEcCtD
Gadodiamide—Feeling abnormal—Doxorubicin—bone cancer	0.00119	0.00119	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Doxorubicin—bone cancer	0.00118	0.00118	CcSEcCtD
Gadodiamide—Pruritus—Methotrexate—bone cancer	0.00118	0.00118	CcSEcCtD
Gadodiamide—Hypersensitivity—Epirubicin—bone cancer	0.00115	0.00115	CcSEcCtD
Gadodiamide—Urticaria—Doxorubicin—bone cancer	0.00115	0.00115	CcSEcCtD
Gadodiamide—Abdominal pain—Doxorubicin—bone cancer	0.00114	0.00114	CcSEcCtD
Gadodiamide—Body temperature increased—Doxorubicin—bone cancer	0.00114	0.00114	CcSEcCtD
Gadodiamide—Diarrhoea—Methotrexate—bone cancer	0.00114	0.00114	CcSEcCtD
Gadodiamide—Asthenia—Epirubicin—bone cancer	0.00112	0.00112	CcSEcCtD
Gadodiamide—Pruritus—Epirubicin—bone cancer	0.0011	0.0011	CcSEcCtD
Gadodiamide—Dizziness—Methotrexate—bone cancer	0.0011	0.0011	CcSEcCtD
Gadodiamide—Diarrhoea—Epirubicin—bone cancer	0.00107	0.00107	CcSEcCtD
Gadodiamide—Hypersensitivity—Doxorubicin—bone cancer	0.00106	0.00106	CcSEcCtD
Gadodiamide—Vomiting—Methotrexate—bone cancer	0.00106	0.00106	CcSEcCtD
Gadodiamide—Rash—Methotrexate—bone cancer	0.00105	0.00105	CcSEcCtD
Gadodiamide—Dermatitis—Methotrexate—bone cancer	0.00105	0.00105	CcSEcCtD
Gadodiamide—Headache—Methotrexate—bone cancer	0.00104	0.00104	CcSEcCtD
Gadodiamide—Asthenia—Doxorubicin—bone cancer	0.00103	0.00103	CcSEcCtD
Gadodiamide—Dizziness—Epirubicin—bone cancer	0.00103	0.00103	CcSEcCtD
Gadodiamide—Pruritus—Doxorubicin—bone cancer	0.00102	0.00102	CcSEcCtD
Gadodiamide—Vomiting—Epirubicin—bone cancer	0.000991	0.000991	CcSEcCtD
Gadodiamide—Nausea—Methotrexate—bone cancer	0.000989	0.000989	CcSEcCtD
Gadodiamide—Diarrhoea—Doxorubicin—bone cancer	0.000987	0.000987	CcSEcCtD
Gadodiamide—Rash—Epirubicin—bone cancer	0.000983	0.000983	CcSEcCtD
Gadodiamide—Dermatitis—Epirubicin—bone cancer	0.000982	0.000982	CcSEcCtD
Gadodiamide—Headache—Epirubicin—bone cancer	0.000976	0.000976	CcSEcCtD
Gadodiamide—Dizziness—Doxorubicin—bone cancer	0.000954	0.000954	CcSEcCtD
Gadodiamide—Nausea—Epirubicin—bone cancer	0.000926	0.000926	CcSEcCtD
Gadodiamide—Vomiting—Doxorubicin—bone cancer	0.000917	0.000917	CcSEcCtD
Gadodiamide—Rash—Doxorubicin—bone cancer	0.000909	0.000909	CcSEcCtD
Gadodiamide—Dermatitis—Doxorubicin—bone cancer	0.000908	0.000908	CcSEcCtD
Gadodiamide—Headache—Doxorubicin—bone cancer	0.000903	0.000903	CcSEcCtD
Gadodiamide—Nausea—Doxorubicin—bone cancer	0.000857	0.000857	CcSEcCtD
